Sofinnova closes $375m fund
The San Francisco-based firm has raised its seventh fund, which will be used for pharmaceutical and IT investments in the US and in Europe.
The San Francisco-based firm has raised its seventh fund, which will be used for pharmaceutical and IT investments in the US and in Europe.
Copyright PEI Media
Not for publication, email or dissemination